Moderna R&D day: $1 billion in cost cuts, 10 product launches
网页2024年9月12日 · Moderna on Thursday said it plans to cut around $1.1 billion in expenses by 2027 and win approvals for several new products as it charts a path forward after the rapid decline of its Covid...
News Details - Moderna
网页2024年3月26日 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
网页August 22, 2024. Today, the U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent...
News Details - Moderna
网页2024年3月27日 · Announces positive clinical trial data from three new vaccines against viruses that cause significant burden (Epstein-Barr virus, Varicella-Zoster virus, norovirus) and advances programs toward Phase 3 development. Anticipates U.S. launch of vaccine against RSV following FDA approval and ACIP recommendation in 2024.
News Details - Moderna
网页2023年9月11日 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines expected to …
Moderna Announces Clinical and Program Updates at 4th …
网页2023年4月11日 · Moderna Announces Clinical and Program Updates at 4th Vaccines Day. April 11, 2023. Download. Next-generation, refrigerator-stable COVID-19 vaccine candidate, mRNA-1283, has dosed first participant in its Phase 3 trial. Company expects to file for approval of its investigational RSV vaccine candidate, mRNA-1345, this quarter.
Moderna says Covid-flu combination vaccine shows positive …
网页2024年6月10日 · Vaccine maker Moderna announced positive late-stage trial results for its Covid-flu combination vaccine. There could be a combined Covid-19 and flu shot in our future, although it won’t be ready...
Moderna Says Its Booster Significantly Raises Antibodies …
网页2021年12月20日 · A booster shot of the Moderna coronavirus vaccine significantly raises the level of antibodies that can thwart the Omicron variant, the company announced on Monday.
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …
网页2023年9月11日 · FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious ...
Moderna says updated booster generated ‘significantly higher ...
网页2022年11月14日 · Moderna said on Monday its updated Covid-19 booster generated “significantly higher” neutralizing antibodies against the Omicron BA.4/BA.5 subvariants than its earlier booster.